Skip to search formSkip to main contentSkip to account menu

ardeparin

Known as: ardeparin [Chemical/Ingredient] 
National Institutes of Health

Related topics

Related topics

11 relations

Broader (3)

AnticoagulantsFibrinolytic AgentsHeparin, Low-Molecular-Weight
Drug AllergyHemorrhagic DisordersPostoperative ComplicationsPulmonary Embolism

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
RETRACTED: Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin
RETRACTED 
2006
2006
Evaluation of the oral bioavailability of low molecular weight heparin formulated with glycyrrhetinic acid as permeation enhancer
Low molecular weight heparin (LMWH) is the agent of choice for anticoagulant therapy and prophylaxis of thrombosis and coronary… 
2005
2005
RETRACTED: Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levels
RETRACTED 
Review
2002
Review
2002
Therapeutic Equivalency of Low-Molecular-Weight Heparins
OBJECTIVE: To review the recent literature on the approved uses of enoxaparin, dalteparin, ardeparin, and tinzaparin and the… 
Review
2002
Review
2002
The low molecular weight heparin, tinzaparin, in thrombosis and beyond.
  • S. Mousa
  • Cardiovascular drug reviews
  • 2002
  • Corpus ID: 37711297
Standard unfractionated heparin (UFH) has been in clinical use for over 50 years. The commercial use of low molecular weight… 
2001
2001
Antithrombin binding of low molecular weight heparins and inhibition of factor Xa.
Highly Cited
1996
Highly Cited
1996
Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery.
BACKGROUND Deep vein thrombosis is common in patients undergoing major knee surgery. Static graduated compression stockings… 
1995
1995
TFPI antigen levels in normal human volunteers after intravenous and subcutaneous administration of unfractionated heparin and a low molecular weight heparin.
Highly Cited
1995
Highly Cited
1995
The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria.
Osteoporosis is a well-recognized complication of long-term heparin use. However, the mechanisms by which heparin can influence… 
Highly Cited
1994
Highly Cited
1994
Ex-vivo and in-vitro evidence that low molecular weight heparins exhibit less binding to plasma proteins than unfractionated heparin.
We have compared the non-specific binding of unfractionated heparin (UFH) with that of low molecular weight heparin (LMWH) to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License